6+ day, 14+ hour ago   (701+ words) Retatrutide has not yet been approved for human use in the UK. That has not stopped fake versions being sold through social media, gyms, beauty salons and unregulated online suppliers. This is the dangerous side of the weight-loss drug boom....

1+ week, 5+ day ago   (288+ words) Concerns about GLP-1 medicines and mental health have been circulating for several years. A new review suggests the strongest evidence does not support a link with major psychiatric harm. They looked at claims that GLP-1 receptor agonists may increase suicidal…...

1+ mon, 19+ hour ago   (307+ words) For decades, people were told to choose low-fat dairy. The logic was simple: dairy contains saturated fat, saturated fat can raise cholesterol, so lower-fat dairy must be healthier. A new Canadian study suggests the real picture is less tidy. Researchers…...

1+ mon, 19+ hour ago   (364+ words) A new oral GLP-1 medicine has shown strong weight loss results in a phase 2 trial. The drug, called aleniglipron, is being developed as a once-daily tablet for people with obesity or overweight. After 36 weeks, people taking the highest dose lost…...

1+ mon, 2+ week ago   (336+ words) The gut and brain are constantly talking. A new rat study suggests one of their conversations may be about memory. Researchers at the University of Southern California studied how the body remembers food-related experiences, such as where food was found....

1+ mon, 2+ week ago   (285+ words) GLP-1 drugs are best known for reducing appetite and supporting blood glucose control. New research suggests some oral GLP-1 drugs may also affect the reward side of eating. That matters because hunger and craving are not the same thing. A…...

2+ mon, 5+ day ago   (293+ words) Intermittent fasting may help people lose weight without the constant mental load of counting calories every day. A new trial from the University of Adelaide compared intermittent fasting with continuous calorie restriction and standard care. More than 200 adults with obesity…...

2+ mon, 4+ day ago   (938+ words) A tablet version of Wegovy has launched privately in the UK, giving people another way to access semaglutide-based weight loss treatment. The pill is taken once a day and is the first oral GLP-1 weight loss medicine approved in the…...

2+ mon, 2+ week ago   (333+ words) GLP-1 drugs have changed obesity and type 2 diabetes treatment, but they are also creating new risks. A study in JAMA Psychiatry suggests people with eating disorders may be using and misusing these medicines at much higher rates than the general…...

2+ mon, 2+ week ago   (331+ words) A major analysis of NHS records suggests obesity in England is now affecting around one in three adults. Researchers examined linked electronic health records covering more than 54 million adults between 2019 and 2025. By April 2025, recorded obesity prevalence had risen to 30.3%. That…...